Decoding Diphtheria: How Genomic Analysis Helps Us Understand This Threat
"A deep dive into a nontoxigenic strain of Corynebacterium diphtheriae and its implications for public health."
Diphtheria, caused by Corynebacterium diphtheriae, remains a significant public health concern despite widespread immunization programs. While toxigenic strains are well-known, nontoxigenic strains are increasingly recognized for their ability to cause severe invasive infections, such as endocarditis and septic arthritis. These infections are not preventable by traditional vaccines, necessitating a deeper understanding of their genomic characteristics.
Recent outbreaks have highlighted the escalating genomic diversity of C. diphtheriae, emphasizing the need to investigate the plasticity and virulence determinants of these strains. This has prompted researchers to explore the genetic makeup of nontoxigenic strains to identify potential factors contributing to their pathogenicity.
A recent study focused on the genomic sequencing, annotation, and analysis of HC07, a nontoxigenic, invasive C. diphtheriae strain isolated from a patient with endocarditis in Rio de Janeiro, Brazil. This research aims to shed light on the genetic underpinnings that enable these strains to cause severe infections.
A Re-Emerging Pathogen With Thin Genomic Surveillance
Recent literature describes Corynebacterium diphtheriae as a re-emerging pathogen of public health concern, with limited genomic data available to support surveillance and public health interventions. Because diphtheria is a reportable disease, jurisdictions such as Minnesota require cases to be reported immediately, around the clock, seven days a week. Genomic studies continue to map the organism's biology, including the iutABCDE operon that encodes an ABC-type iron uptake system with periplasmic, ATP-binding, membrane, and substrate-binding components. Together these observations point to a pathogen whose epidemiology is shifting faster than the genomic surveillance needed to track it.
Toxin Gene Detection Backed by Antitoxin and Antibiotics
Current diagnostic methods centre on detecting the tox gene and distinguishing C. diphtheriae from the closely related C. ulcerans and C. pseudotuberculosis; one described approach also differentiates the newly named species Corynebacterium belfantii and demonstrated complete diagnostic specificity, sensitivity, and experimental robustness. On the clinical side, treatment must begin immediately after clinical diagnosis to prevent complications, combining antitoxin therapy and antibiotics, each serving a distinct purpose. The organism itself is an aerobic, Gram-positive bacillus whose main danger lies not in colonizing the mucous membrane itself but in producing diphtheria toxin. Established protocols therefore pair molecular toxin-gene detection with prompt antitoxin-based treatment.
From a Club-Shaped Name to a Global Foe
Corynebacterium diphtheriae is a globally important Gram-positive aerobic Actinobacterium capable of causing the toxin-mediated disease diphtheria. The organism takes its name from Greek roots—'Coryne' meaning club and 'diphtheriae' meaning leather—reflecting its club-shaped morphology and the leathery pseudomembrane it forms. Reference and educational resources consistently frame it as an 'old foe' whose foundational discovery established the link between a bacterium, a secreted toxin, and a devastating childhood disease. That early recognition remains the cornerstone of modern understanding of the pathogen.
Unveiling the Genomic Landscape of HC07
The HC07 strain, belonging to biotype gravis, was isolated in 2013 and identified through conventional microbiological methods and the API Coryne System. The strain was confirmed to be nontoxigenic via the modified Elek test and Vero cell cytotoxicity assay. Multilocus sequence typing (MLST) revealed that HC07 corresponds to sequence type ST-171, further classifying its genetic profile.
- Total genome size: 2,491,635 bp
- GC content: 53.53%
- Number of genes: 2,333
- rRNAs: 6 (5S, 16S, 23S) and tRNAs: 51
Toxigenic and Nontoxigenic Disease: A Growing Research Focus
Recent reviews describe diphtheria as a respiratory infection typically caused by toxigenic C. diphtheriae strains that prevalently affects children and can be fatal, though vaccination can effectively prevent the disease. Case reports add nuance by showing that infections arise from both toxigenic and nontoxigenic strains: the first documented case of cutaneous diphtheria in Malaysia involved a toxigenic strain, while blood cultures confirmed nontoxigenic C. diphtheriae in a fully vaccinated pediatric patient. Other work is applying structural genomics to the pathogen, including analyses of its druggable pocketome across multiple strains. Together these studies reflect renewed interest in the organism's epidemiology, pathogenesis, and potential therapeutic targets.
Indifference and the Limits of Complacency
The Microbiology Society warns pointedly that C. diphtheriae 'cares not for our indifference,' noting that this aerobic, Gram-positive organism includes strains that produce the deadly diphtheria toxin. The bacterium causes disease by making toxins that can trigger serious symptoms, including respiratory and heart problems, so understanding how it causes disease is central to finding effective treatments. Educational materials repeatedly stress that only some strains are toxigenic, which makes the threat easy to underestimate. The persistence of diphtheria despite vaccination programs is a reminder that surveillance and awareness must not lapse.
A True Pathogen Versus a Benign Look-Alike
Corynebacterium diphtheriae and diphtheroids are two types of bacteria that share some similarities but also have distinct differences. C. diphtheriae is the causative agent of diphtheria, a potentially life-threatening respiratory infection, whereas diphtheroids are typically non-pathogenic commensals encountered in routine cultures. The pathogen infects the nasopharynx or skin, and toxigenic strains secrete a potent exotoxin that may cause diphtheria. This contrast between a genuine pathogen and its benign look-alikes is central to correct laboratory interpretation.
Implications for Public Health and Future Research
The genomic analysis of HC07 provides valuable insights into the diversity and plasticity of nontoxigenic C. diphtheriae strains. The presence of specific virulence factors, a unique prophage, and various genomic islands highlights the complex genetic adaptations that contribute to the bacterium's pathogenicity. Further research is needed to fully understand the mechanisms driving the evolution and persistence of these strains and their implications for public health. Continued genomic surveillance and analysis will be crucial in developing effective strategies to combat infections caused by nontoxigenic C. diphtheriae.
An Old Etiological Agent That Never Went Away
Corynebacterium diphtheriae remains the principal cause of diphtheria, a disease characterised by a fibrinous pseudomembrane in the respiratory tract, systemic toxin-mediated damage, and potentially fatal complications. As the etiological agent of diphtheria, the organism is a re-emerging pathogen responsible for several thousand deaths per year. Beyond classic respiratory diphtheria, systemic infections—often caused by nontoxigenic strains—are increasingly observed. Expert summaries therefore describe diphtheria not as a conquered disease but as a persistent, evolving threat.
Rapid Molecular Detection and the Vaccine Blind Spot
CDC field notes report that C. diphtheriae infections can be caused by both toxigenic and nontoxigenic strains, and that diphtheria toxoid–containing vaccines (DTaP, Tdap, Td) only protect against toxigenic strains—a key gap as nontoxigenic disease rises. This has made the organism a significant public health concern in emerging markets and vaccine-hesitant populations, necessitating rapid and accurate detection capabilities. A growing market for C. diphtheriae nucleic acid detection kits, built around nucleic acid amplification tests and real-time PCR kits, reflects that demand, though the industry faces challenges related to supply chain bottlenecks. Future surveillance is likely to pair genomic sequencing with these rapid molecular tools.
From Leading Childhood Killer to Lapsing Immunity
Prior to the introduction of the toxoid vaccine, diphtheria was a major cause of childhood mortality. C. diphtheriae remains a globally important Gram-positive aerobic Actinobacterium capable of causing the toxin-mediated disease diphtheria. The very success of vaccination reshaped the epidemiology and, with it, collective memory of the disease—yet the organism persists wherever immunity wanes or coverage lapses. Sustaining control therefore depends on maintaining vaccination coverage and laboratory capacity, not on the assumption that diphtheria has disappeared.
Outbreaks in Migrant Populations and the Return of a Familiar Disease
A study of a diphtheria outbreak among migrant populations in Europe identified 362 cases of diphtheria and 363 isolates collected from January through November 2022, with case counts in each reporting country tracked by month. This pattern echoes an earlier trend, as confirmed isolates of nontoxigenic C. diphtheriae in England and Wales increased substantially from 1986 to 1994. Cases like these show diphtheria striking vulnerable and mobile populations, from migrants to under-vaccinated communities. Each outbreak is a reminder that the disease resurfaces where people, movement, and gaps in immunity intersect.